MDR

9-(2-DEOXY-BETA-D-RIBOFURANOSYL)-6-METHYLPURINE

Find entries where: MDR

is present as a standalone ligand in 2 entries

Find related ligands:

Chemical Component Summary
Name	9-(2-DEOXY-BETA-D-RIBOFURANOSYL)-6-METHYLPURINE
Identifiers	(2R,3S,5R)-2-(hydroxymethyl)-5-(6-methylpurin-9-yl)oxolan-3-ol
Formula	C₁₁ H₁₄ N₄ O₃
Molecular Weight	250.254
Type	DNA LINKING
Isomeric SMILES	Cc1c2c(ncn1)n(cn2)[C@H]3C[C@@H]([C@H](O3)CO)O
InChI	InChI=1S/C11H14N4O3/c1-6-10-11(13-4-12-6)15(5-14-10)9-2-7(17)8(3-16)18-9/h4-5,7-9,16-17H,2-3H2,1H3/t7-,8+,9+/m0/s1
InChIKey	SJXRKKYXNZWKDB-DJLDLDEBSA-N

Chemical Details
Formal Charge	0
Atom Count	32
Chiral Atom Count	3
Bond Count	34
Aromatic Bond Count	10

Drug Info: DrugBank

DrugBank ID	DB03735
Name	9-(2-Deoxy-Beta-D-Ribofuranosyl)-6-Methylpurine
Groups	experimental
Synonyms	9-(2-Deoxy-Beta-D-Ribofuranosyl)-6-Methylpurine

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Purine nucleoside phosphorylase DeoD-type	MATPHINAEMGDFADVVLMPGDPLRAKYIAETFLEDAREVNNVRGMLGFT...	unknown

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682